FF
DYN icon

FourThought Financial’s Dyne Therapeutics DYN Stock Holding History

FourThought Financial’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$20K Buy
+1,563
New +$17.9K ﹤0.01% 857
2022
Q1 		– Sell
-671
Closed -$8K – 1488
2021
Q4 		$8K Hold
671
– – ﹤0.01% 1107
2021
Q3 		$10K Hold
671
– – ﹤0.01% 1101
2021
Q2 		$14K Hold
671
– – ﹤0.01% 1026
2021
Q1 		$10K Buy
+671
New +$13K ﹤0.01% 1054

Other funds holding DYN

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FourThought Financial's DYN Position: Q3 2022 in Review

FourThought Financial opened a new position in Dyne Therapeutics (DYN) in Q3 2022: 1,563 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #857 among its holdings. This is a return to the name: FourThought Financial previously reported a position in DYN as recently as Q4 2021.

FourThought Financial first reported a position in DYN in Q1 2021 and has held it in 5 quarters since. 102 funds tracked by Wall St. Rank hold DYN as of Q3 2022.

  • FourThought Financial held 1,563 shares of Dyne Therapeutics worth $20K as of Q3 2022.
  • Dyne Therapeutics was a new FourThought Financial position in Q3 2022.
  • Dyne Therapeutics made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #857 holding.
  • FourThought Financial first reported a position in Dyne Therapeutics in Q1 2021 and has held it in 5 quarters since.
  • 102 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.